Searched for
PAONTA SAHIB PLANT
Daiichi to cooperate with USFDA to resolve Ranbaxy concernsDaiichi Sankyo will work with US authorities to resolve issue of a ban imposed by USFDA on import of drugs from Mohali plant of Ranbaxy.24 Sep, 2013, 04.06 PM IST- Ranbaxy seeks to assuage shareholders' worries after USFDA banRanbaxy Laboratories today sought to assuage concerns of shareholders in the wake of company's stock price taking a hard knock.21 Sep, 2013, 09.19 AM IST
- Certain consent decree terms to apply to Mohali unit: RanbaxyThe decree contains provisions to ensure CGMP (Current Good Manufacturing Practices) compliance at certain Ranbaxy facilities.17 Sep, 2013, 05.20 PM IST
- PIL seeking cancellation of Ranbaxy licence filed in Supreme CourtA plea has been filed in the SC seeking cancellation of Ranbaxy's licence on the grounds that it fudged data and sold adulterated products ...06 Jun, 2013, 09.28 AM IST
- Ranbaxy's issues with USFDA can adversely affect biz: DaiichiDaiichi Sankyo today said its business could suffer adversely in the medium to long-term if Indian subsidiary Ranbaxy's problems with the U...12 May, 2010, 07.54 PM IST
- Ranbaxy looks to rebuild its US businessFaced with massive losses coupled with regulatory hurdles in the American market, Ranbaxy Laboratories Ltd has chalked out plans to revamp ...17 May, 2009, 11.44 AM IST
- Daiichi to meet US FDA to resolve Ranbaxy issueDaiichi Sankyo, the Japanese pharmaceutical company that bought Ranbaxy Laboratories last year, will meet US FDA officials next month to so...01 Apr, 2009, 12.33 AM IST
- Reliance Money upgrades Ranbaxy to ‘BUY’; target price Rs 189Given the attractive valuations at current levels, Reliance Money has upgraded its rating on Ranbaxy Laboratories from ‘hold’ to ‘buy’ with...25 Mar, 2009, 12.55 PM IST
- Ranbaxy under pressure on Australia probe reportShares of Ranbaxy Laboratories dropped to a 52-week low on reports the Australian pharmaceutical regulator is investigating allegations by ...05 Mar, 2009, 02.51 PM IST
- Aussie regulator puts Ranbaxy under scannerThe Australian drug regulator Therapeutic Goods Administration (TGA) said it is reviewing 62 drugs sold in the country which are made by Ra...05 Mar, 2009, 12.36 AM IST
- Ranbaxy down another 4% weighed by USFDA actionShares of Ranbaxy Laboratories continued to witness fresh selling pressure on Friday. The stock was trading at Rs 164, losing another 4% in...27 Feb, 2009, 10.24 AM IST
- Ranbaxy says to take steps to protect revenue lossIndia’s largest drug company Ranbaxy said the US drug regulator’s decision to halt approval of drugs from one of its plants in India will a...26 Feb, 2009, 02.45 PM IST
- Ranbaxy falls 12% on USFDA regulatory actionShares of Ranbaxy Laboratories were under selling pressure, on reports of USFDA initiating new regulatory action against the company.26 Feb, 2009, 10.23 AM IST
- US regulator charges Ranbaxy of falsifying data, test resultsTo address falsified data, FDA has invoked its Application Integrity Policy (AIP) against Paonta Sahib facility. Factors for successful M&A...26 Feb, 2009, 06.30 AM IST
- Ranbaxy rebounds 7% on CEO's clarificationShares of Ranbaxy Laboratories bounced back Wednesday after Chief Executive Officer Malvinder Singh clarified on the Daiichi Sankyo stake b...16 Jul, 2008, 11.14 AM IST
- Ranbaxy faces adulteration charges in USUS department of justice has said there was evidence to suggest that Ranbaxy used active pharmaceutical ingredients from unapproved sources...14 Jul, 2008, 12.34 AM IST
- USFDA issues warning to RanbaxyThe USFDA has issued a warning letter to domestic pharma major Ranbaxy for deviations from good manufacturing practices at its Paonta Sahib...27 Jun, 2006, 12.57 AM IST
Load More
